Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Common Equity (2016 - 2026)

MedWellAI has reported Common Equity over the past 11 years, most recently at -$7.5 million for Q4 2025.

  • Quarterly Common Equity fell 43.19% to -$7.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.5 million through Dec 2025, down 43.19% year-over-year, with the annual reading at -$6.5 million for FY2025, 67.13% down from the prior year.
  • Common Equity was -$7.5 million for Q4 2025 at MedWellAI, down from -$7.1 million in the prior quarter.
  • Over five years, Common Equity peaked at $11.5 million in Q4 2021 and troughed at -$7.5 million in Q4 2025.
  • The 5-year median for Common Equity is -$980040.0 (2023), against an average of $1.7 million.
  • Year-over-year, Common Equity surged 22176.0% in 2021 and then tumbled 658.11% in 2024.
  • A 5-year view of Common Equity shows it stood at $11.5 million in 2021, then dropped by 24.81% to $8.6 million in 2022, then crashed by 119.84% to -$1.7 million in 2023, then plummeted by 204.73% to -$5.2 million in 2024, then tumbled by 43.19% to -$7.5 million in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Common Equity are -$7.5 million (Q4 2025), -$7.1 million (Q3 2025), and -$6.5 million (Q2 2025).